← Leaderboards
E Sherwood Brown
Ut Southwestern Medical Center
$23,442,176
Attributed
$34,293,753
Total exposure
22
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,293,753 · 22
By mechanism
R01$26,367,978 · 10
R21$2,226,956 · 5
R18$1,823,698 · 1
R61$1,439,864 · 2
K08$827,601 · 1
R33$806,508 · 1
Top collaborators
- Marlene P Freeman5 shared
- Bruce D Miller5 shared
- Thomas Ekkehard Ritz5 shared
- Ihsan M Salloum5 shared
- Beatrice L Wood5 shared
- Michael A Yassa5 shared
- David A Khan2 shared
- Mack Clarence Mitchell2 shared
Others in their field
Top investigators on “Depressive Symptoms”
- Boris Birmaher · University Of Pittsburgh At Pittsburgh$29,469,356
- Carol D. Ryff · University Of Wisconsin Madison$24,913,546
- Margarita Alegria · Massachusetts General Hospital$23,547,088
- Monica G Rivera-Mindt · Fordham University$22,492,039
- Janice K Kiecolt-Glaser · Ohio State University$21,246,822
- Madhukar H Trivedi · University Of Texas Sw Med Ctr/Dallas$21,229,187
Research focus
Depressive SymptomsMoodsMood DisordersPlacebosSymptomsPharmaceutical PreparationsReportingBaseRandomizedClinical TrialsSeveritiesMemoryDouble-Blind MethodLiteratureAsthmaOutcome MeasureBipolar DisorderPersonsOutpatientsAntidepressive AgentsResponseProgramsCognitionDose
Grant awards (85)
A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent Exacerbations$806,508
R33 · FY2025 · HL · contact PI
Integrated therapies for alcohol use and ALD (ITAALD) Network â UTSW Clinical Center$360,800
U01 · FY2025 · AA
T35 NIAAA Summer Research Program$27,166
T35 · FY2025 · AA · contact PI
A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent Exacerbations$790,698
R61 · FY2024 · HL · contact PI
Integrated therapies for alcohol use and ALD (ITAALD) Network â UTSW Clinical Center$360,800
U01 · FY2024 · AA
T35 NIAAA Summer Research Program$26,709
T35 · FY2024 · AA · contact PI
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging$727,900
R01 · FY2023 · MH · contact PI
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression$696,173
R01 · FY2023 · AG · contact PI
T35 NIAAA Summer Research Program$25,673
T35 · FY2023 · AA
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging$735,974
R01 · FY2022 · MH · contact PI
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging$744,839
R01 · FY2021 · MH · contact PI
The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)$725,468
R01 · FY2021 · HL
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression$706,539
R01 · FY2021 · AG · contact PI
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging$793,371
R01 · FY2020 · MH · contact PI
The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)$732,741
R01 · FY2020 · HL
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression$709,593
R01 · FY2020 · AG · contact PI
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder$475,593
R01 · FY2020 · AA · contact PI
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging$817,036
R01 · FY2019 · MH · contact PI
Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators -$751,765
R01 · FY2019 · HL · contact PI
The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)$741,403
R01 · FY2019 · HL
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression$686,651
R01 · FY2019 · AG · contact PI
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders$640,390
R01 · FY2019 · AA · contact PI
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder$563,831
R01 · FY2019 · AA · contact PI
The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)$417,675
R01 · FY2019 · HL
Development of Pregnenolone as a Treatment for Depression$312,375
R61 · FY2019 · AT · contact PI
Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators -$775,595
R01 · FY2018 · HL · contact PI
The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)$773,895
R01 · FY2018 · HL
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression$730,442
R01 · FY2018 · AG · contact PI
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders$663,731
R01 · FY2018 · AA · contact PI
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder$563,831
R01 · FY2018 · AA · contact PI
Development of Pregnenolone as a Treatment for Depression$336,791
R61 · FY2018 · AT · contact PI
Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators -$780,872
R01 · FY2017 · HL · contact PI
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders$661,620
R01 · FY2017 · AA · contact PI
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder$563,831
R01 · FY2017 · AA · contact PI
Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators -$790,137
R01 · FY2016 · HL · contact PI
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders$667,050
R01 · FY2016 · AA · contact PI
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder$543,269
R01 · FY2016 · AA · contact PI
Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators -$825,118
R01 · FY2015 · HL · contact PI
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders$700,994
R01 · FY2015 · AA · contact PI
Attenuation of Corticosteroid-Induced Hippocampal Changes$299,526
R01 · FY2015 · DA · contact PI
Citicoline for Alcohol Dependence$221,705
R21 · FY2015 · AA · contact PI
Attenuation of Corticosteroid-Induced Hippocampal Changes$5,076
R01 · FY2015 · DA · contact PI
Reversing Corticosteroid-Induced Memory Impairment$275,468
R01 · FY2014 · MH · contact PI
Attenuation of Corticosteroid-Induced Hippocampal Changes$270,300
R01 · FY2014 · DA · contact PI
Icariin to Prevent Corticosteroid-Related Memory Changes$192,787
R21 · FY2014 · AT · contact PI
Citicoline for Alcohol Dependence$188,813
R21 · FY2014 · AA · contact PI
Antidepressant Treatment at an Inner City Asthma Clinic$107,565
R18 · FY2014 · HL · contact PI
Antidepressant Treatment at an Inner City Asthma Clinic$428,691
R18 · FY2013 · HL · contact PI
Attenuation of Corticosteroid-Induced Hippocampal Changes$259,488
R01 · FY2013 · DA · contact PI
Reversing Corticosteroid-Induced Memory Impairment$226,670
R01 · FY2013 · MH · contact PI
Icariin to Prevent Corticosteroid-Related Memory Changes$226,575
R21 · FY2013 · AT · contact PI
Attenuation of Corticosteroid-Induced Hippocampal Changes$6,156
R01 · FY2013 · DA · contact PI
Antidepressant Treatment at an Inner City Asthma Clinic$428,428
R18 · FY2012 · HL · contact PI
Citicoline for Bipolar Disorder and Cocaine Dependence$338,697
R01 · FY2012 · DA · contact PI
Attenuation of Corticosteroid-Induced Hippocampal Changes$269,734
R01 · FY2012 · DA · contact PI
Reversing Corticosteroid-Induced Memory Impairment$235,682
R01 · FY2012 · MH · contact PI
Citicoline for Bipolar Disorder and Cocaine Dependence$6,156
R01 · FY2012 · DA · contact PI
Antidepressant Treatment at an Inner City Asthma Clinic$427,349
R18 · FY2011 · HL · contact PI
Citicoline for Bipolar Disorder and Cocaine Dependence$338,697
R01 · FY2011 · DA · contact PI
Quetiapine for Bipolar Disorder and Alcohol Dependence$268,919
R01 · FY2011 · AA · contact PI
Reversing Corticosteroid-Induced Memory Impairment$235,373
R01 · FY2011 · MH · contact PI
Antidepressant Treatment at an Inner City Asthma Clinic$431,665
R18 · FY2010 · HL · contact PI
Citicoline for Bipolar Disorder and Cocaine Dependence$350,986
R01 · FY2010 · DA · contact PI
Quetiapine for Bipolar Disorder and Alcohol Dependence$288,644
R01 · FY2010 · AA · contact PI
Reversing Corticosteroid-Induced Memory Impairment$237,750
R01 · FY2010 · MH · contact PI
Citicoline for Bipolar Disorder and Cocaine Dependence$357,918
R01 · FY2009 · DA · contact PI
Quetiapine for Bipolar Disorder and Alcohol Dependence$282,600
R01 · FY2009 · AA · contact PI
Development of a Model to Examine Corticosteroid Effects on the Hippocampus$211,950
R21 · FY2009 · MH · contact PI
Quetiapine for Bipolar Disorder and Alcohol Dependence$19,991
R01 · FY2009 · AA · contact PI
Citicoline for Bipolar Disorder and Cocaine Dependence$13,662
R01 · FY2009 · DA · contact PI
Citicoline for Bipolar Disorder and Cocaine Dependence$359,766
R01 · FY2008 · DA · contact PI
Quetiapine for Bipolar Disorder and Alcohol Dependence$356,415
R01 · FY2008 · AA · contact PI
Development of a Model to Examine Corticosteroid Effects on the Hippocampus$176,625
R21 · FY2008 · MH · contact PI
Quetiapine for Bipolar Disorder and Alcohol Dependence$282,600
R01 · FY2007 · AA · contact PI
Quetiapine for Bipolar Disorder and Alcohol Dependence$74,377
R01 · FY2007 · AA · contact PI
Naltrexone for Bipolar Disorder and Alcohol Dependence$228,501
R21 · FY2006 · AA · contact PI
Naltrexone for Bipolar Disorder and Alcohol Dependence$195,000
R21 · FY2005 · AA
Treating Asthma Patients with Major Depressive Disorder$195,000
R21 · FY2004 · MH
HIPPOCAMPAL FUNCTION DURING CORTICOSTEROID THERAPY$167,139
K08 · FY2004 · MH
Treating Asthma Patients with Major Depressive Disorder$195,000
R21 · FY2003 · MH
HIPPOCAMPAL FUNCTION DURING CORTICOSTEROID THERAPY$168,969
K08 · FY2003 · MH
Treating Asthma Patients with Major Depressive Disorder$195,000
R21 · FY2002 · MH
HIPPOCAMPAL FUNCTION DURING CORTICOSTEROID THERAPY$167,497
K08 · FY2002 · MH
HIPPOCAMPAL FUNCTION DURING CORTICOSTEROID THERAPY$163,532
K08 · FY2001 · MH
HIPPOCAMPAL FUNCTION DURING CORTICOSTEROID THERAPY$160,464
K08 · FY2000 · MH